Inari Medical, Inc.
NARI
Kedudukan dalam Saham
#3686
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Harga Saham
$79.97
Disegerakkan terakhir: 2025-02-19
Modal Pasaran
$4.57B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Inari Medical, Inc. (NARI)
Kategori
Healthcare
Hasil untuk Inari Medical, Inc. (NARI)
Hasil pada Sep 2024 TTM: $574.50M
Menurut laporan kewangan terkini daripada Inari Medical, Inc., hasil semasa syarikat (TTM) ialah $574.50M. Pada tahun 2022, syarikat memperoleh hasil sebanyak $383.47M peningkatan berbanding hasil pada tahun 2021 iaitu $276.98M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Inari Medical, Inc. dari 2018 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $574.50M | 16.38% |
| 2023 | $493.63M | 28.73% |
| 2022 | $383.47M | 38.45% |
| 2021 | $276.98M | 98.31% |
| 2020 | $139.67M | 173.17% |
| 2019 | $51.13M | 648.70% |
| 2018 | $6.83M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $46.59B | 8,008.82% |
US
|
|
| $35.48B | 6,076.52% |
IE
|
|
| $25.84B | 4,397.32% |
US
|
|
| $21.00B | 3,554.67% |
US
|
|
| - | - |
DE
|
